Recent Finacing
Recent Raise
Nuclea Biotechnologies develops translational-medicine clinical diagnostic assays that identify tumor gene and protein biomarkers and predict therapeutic response and recurrence risk in colon, breast, leukemia, lung, and prostate cancers.